Which protein vaccines against Covid-19 are already approved or under development in Switzerland?

Novavax's protein vaccine against Covid-19 (NVX-CoV2373; Nuvaxovid) is approved in Switzerland. It is expected to be available in the second quarter 2022.

Internationally, other protein vaccines are in development, including by Sanofi and Glaxo-Smithkline (GSK).